Noxopharm Limited has announced a partnership with Doherty Clinical Trials to conduct the HERACLES clinical trial in Melbourne. This collaboration aims to leverage the expertise of Doherty Clinical Trials in early phase studies and immunology to advance Noxopharm’s innovative SOF-SKN™ drug for lupus.